The laminin binding integrins (LB integrins) play critical roles during carcinoma initiation, progression, metastasis, and survival. Among the different integrins, only the LB integrins (a6?1, a6?4, a3?1, a7?1) undergo palmitoylation, and associate closely with tetraspanin CD151, which enables their recruitment into tetraspanin-enriched microdomains. In this context, CD151 and other associated partner proteins regulate LB integrin-dependent cell spreading, motility, signaling, adhesion strengthening, EGFR collaboration, and lateral diffusion, on epithelial, endothelial and other cell types. CD151 itself also associates positively with tumor cell malignancy, in multiple carcinoma types. In this regard, our CD151 knockout mice are deficient in hosting primary and/or secondary tumor growth in ectopic tumor injection models, and in a spontaneous mouse mammary tumor model. This host defect in CD151-null mice is due, at least in part, to a deficit in pathological angiogenesis. Tumor cell CD151 also notably supports tumor progression, as seen in both orthotopic and ectopic xenograft models. Consequently, we hypothesize that tetraspanin CD151 uses extracellular, intracellular, and lateral association sites to link LB integrins to tetraspanin-enriched microdomains, which contributes to the specialized functional properties of laminin-binding integrins, and promotes tumor cell malignancy. To test this model, we will carry out a comprehensive analysis of LB integrin and CD151-associated molecules, cytoskeletal interactions, and dominant negative mutations, both in vitro, and in vivo during primary and secondary tumor growth.
In Aim 1 we will use a differential mass spectrometry approach to identify additional membrane and cytoskeletal partner proteins for LB integrins, as well as possible compensating proteins, which preferentially associate with LB integrins when CD151 is absent.
In Aim 2, we will sort out positive and negative effects, exerted by the cytoskeleton on LB integrin functions, and on the EGFR.
Aim 3 will be used to amplify disruption of LB integrin functions, using a) dominant negative mutant forms of CD151, b) knockdown of proteins that may compensate for CD151 absence, and c) knockdown of supporting proteins.
In Aim 4, we will learn the extent to which LB integrin complexes contribute to primary tumor growth in vivo, using transgenic mouse models of spontaneous mammary cancer.
Aim 5 will study, in both tumor and host, the effects of LB integrin complex disruption on metastasis.

Public Health Relevance

LB integrins and CD151 have been implicated in tumor progression at many levels, including tumor initiation, primary growth, and metastasis, through tumor effects and host animal effects. Our preliminary results suggest that disruption of LB integrin complexes, largely by deleting or modifying CD151, profoundly affects tumor progression, while minimally affecting normal physiology. Our proposed studies of this alternative method for modulating LB integrins should lead to novel strategies for therapeutic intervention in breast cancer and other cancers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Snyderwine, Elizabeth G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dana-Farber Cancer Institute
United States
Zip Code
Sharma, Chandan; Hemler, Martin E (2017) Multiple pro-tumor roles for protein acyltransferase DHHC3. Oncoscience 4:152-153
Ficarro, Scott B; Alexander, William M; Marto, Jarrod A (2017) mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry Data. Proteomes 5:
Sharma, Chandan; Wang, Hong-Xing; Li, Qinglin et al. (2017) Protein Acyltransferase DHHC3 Regulates Breast Tumor Growth, Oxidative Stress, and Senescence. Cancer Res 77:6880-6890
Wang, Hong-Xing; Sharma, Chandan; Knoblich, Konstantin et al. (2015) EWI-2 negatively regulates TGF-? signaling leading to altered melanoma growth and metastasis. Cell Res 25:370-85
Wang, Hong-Xing; Hemler, Martin E (2015) Novel impact of EWI-2, CD9, and CD81 on TGF-? signaling in melanoma. Mol Cell Oncol 2:
Hemler, Martin E (2014) Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer 14:49-60
Knoblich, Konstantin; Wang, Hong-Xing; Sharma, Chandan et al. (2014) Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits ?-catenin degradation. Cell Mol Life Sci 71:1305-14
Li, Q; Yang, X H; Xu, F et al. (2013) Tetraspanin CD151 plays a key role in skin squamous cell carcinoma. Oncogene 32:1772-83
Deng, Xinyu; Li, Qinglin; Hoff, John et al. (2012) Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia 14:678-89
Yang, Xiuwei H; Mirchev, Rossen; Deng, Xinyu et al. (2012) CD151 restricts the ?6 integrin diffusion mode. J Cell Sci 125:1478-87

Showing the most recent 10 out of 61 publications